---
$id: https://graph.org.ai/products/commodity/51162610
$type: Product
source: UNSPSC
code: "51162610"
title: "Bibenzonium bromide"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bibenzonium bromide

**UNSPSC Code**: 51162610
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular formula C19H26NO.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4455J9277Q, chemically known as (2-(1,2-diphenylethoxy)ethyltrimethyl)ammonium bromide but more generally known as bibenzonium bromide, which bears US NIH Compound Identifier 85001. European Medicines Agency schedules Bibenzonium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05815MIG. The term BIBENZONIUM BROMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). World Health Organization schedules bibenzonium bromide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule bibenzonium bromide under HS 29239000 and SITC 51481. As of Q4 2014, BIBENZONIUM BROMIDE remains US FDA's Preferred Term for this commodity. Bibenzonium bromide bears US NLM identifiers UMLS ID C2347007 and NCI Concept Code C73180. SMILES: C[N+](C)(C)CCOC(CC1CCCCC1)C2CCCCC2.[BR-].

